Page last updated: 2024-10-28

hydroxyzine and Mucocutaneous Lymph Node Syndrome

hydroxyzine has been researched along with Mucocutaneous Lymph Node Syndrome in 1 studies

Hydroxyzine: A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
hydroxyzine : A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.

Mucocutaneous Lymph Node Syndrome: An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Jindal, AK1
Indla, RT1
Pilania, RK1
Singh, S1

Other Studies

1 other study available for hydroxyzine and Mucocutaneous Lymph Node Syndrome

ArticleYear
Non-Exudative Conjunctival Injection With Limbal Sparing: A Pathognomonic Clinical Sign of Kawasaki Disease.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2020, Volume: 26, Issue:3

    Topics: Child; Echocardiography; Humans; Hydroxyzine; Immunoglobulins, Intravenous; Male; Mucocutaneous Lymp

2020